Privacy Policy
Effective Date: August 21, 2020
Millicent Pharma Limited (“Millicent Pharma” “we,” “our,” or “us”), provides this privacy policy (“Privacy Policy”) to describe how we collect, use, and share the information of individuals who visit our websites at femring.com, us.intrarosa.com, or any other website we own or operate or that links to this Privacy Policy (the “Site(s)”). Unless otherwise defined in this Privacy Policy, terms used in this Privacy Policy have the same meanings as terms defined in our Terms of Service.
Information Collection
When using our Sites or interacting with us, you may voluntarily provide information about yourself, including your name, email address, and any other information you choose to provide. We collect this information when you send an email to us requesting information or interact with us for any other purpose.
We collect information relating to your interactions with us and our Site, including browser type, IP address, pages visited and other activities on the Site, device type, and time and date of visit, and other information we collect through the use of cookies and similar technology.
Information Use
We may use your information for any lawful purpose, including the following:
- To respond to your inquiries;
- To operate and improve our services, including to provide better services, products, and opportunities to our customers and visitors to our Sites;
- To operate, personalize, and improve our Sites, including for analytics purposes;
- To send surveys, promotions, and marketing materials that may be of interest to you;
- To comply with the law and to maintain the security of our Sites; or
- With your consent, or as otherwise disclosed at the time information is collected.
Information Sharing
We may share the information we collect with third parties, including the following:
- With service providers who perform various functions on our behalf;
- As part of a corporate sale, merger, or acquisition, or other transfer of all or part of our assets, including as part of a bankruptcy proceeding;
- Pursuant to a subpoena, court order, governmental inquiry, or other legal process or as otherwise required by law, or to protect our rights or the rights of third parties;
- With your consent or as otherwise disclosed at the time of data collection or sharing.
We may share information that has been de-identified or aggregated without limitation.
Analytics
We may work with third parties that collect data about your use of our Sites and other sites or apps over time for non-advertising purposes. Millicent Pharma uses Google Analytics and other third-party services to improve the performance of our Sites and for analytics and marketing purposes. For more information about how Google Analytics collects and uses data when you use our Site, visit www.google.com/policies/privacy/partners, and to opt out of Google Analytics, visit tools.google.com/dlpage/gaoptout.
Third-Party Links and Tools
Our Sites may provide links to third-party websites or apps. We do not control the privacy practices of those websites or apps, and they are not covered by this Privacy Policy. You should review the privacy policies of other websites or apps that you use to learn about their data practices.
Our Sites may also include integrated social media tools or “plug-ins,” such as social networking tools offered by third parties. If you use these tools to share personal information or you otherwise interact with these features on the Site, those companies may collect information about you and may use and share such information in accordance with your account settings, including by sharing such information with the general public. Your interactions with third-party companies and your use of their features are governed by the privacy policies of the companies that provide those features. We encourage you to carefully read the privacy policies of any accounts you create and use.
Your California Privacy Rights
Under the California Consumer Protection Act (“CCPA”), California residents have certain rights with respect to the personal information collected by businesses. This section contains disclosures required by the CCPA and applies only to “personal information” about California consumers that is subject to the CCPA (“California Personal Information”).
California Personal Information We Collect and Share for a Business Purpose. We collect the following categories of California Personal Information:
| Categories of California Personal Information Collected | Disclosed for business purposes to the following categories of third parties: |
|---|---|
| Personal and online identifiers (such as first and last name, email address, or unique online identifiers) | All categories listed below. |
| Categories of information described in Section 1798.80(e) of the California Civil Code (such as physical characteristics or description, insurance policy number, bank account number, credit card number, debit card number, or any other financial information, medical information, or health insurance information) | All categories listed below. |
| Characteristics of protected classifications under California or federal law (such as race or gender) | All categories listed below. |
| Commercial or transactions information (such as records of personal property or products or services purchased, obtained or considered) | All categories listed below. |
| Internet or other electronic network activity information (such as browsing history, search history, interactions with a website, email, application, or advertisement) | All categories listed below. |
| Biometric information (such as call recordings) | All categories listed below. |
| Geolocation information | All categories listed below. |
Categories of Sources. We and our service providers, acting on our behalf, collect California Personal Information from the following categories of sources:
- From consumers;
- From service providers we have engaged to provide services to us or on our behalf;
- From our affiliates; and
- From non-affiliated third parties, such as pharmacies or copay programs that may collect personal information on our behalf.
Why We Use and Disclose California Personal Information. We and our service providers, acting on our behalf, use and disclose California Personal Information we collect for our commercial and business purposes, as further described in this Privacy Policy. These purposes include, without limitation:
- Our commercial purposes, including marketing and facilitating transactions.
- Our business purposes as identified in the CCPA, which include:
- Auditing related to our interactions with you;
- Detecting and protecting against security incidents, fraud, and illegal activity;
- Debugging;
- Performing services (for us or our service provider) such as account servicing, processing orders and payments, and analytics;
- Internal research for technological improvement;
- Activities to maintain and improve our services; and
- Other one-time uses.
- Auditing related to our interactions with you;
- Detecting and protecting against security incidents, fraud, and illegal activity;
- Debugging;
- Performing services (for us or our service provider) such as account servicing, processing orders and payments, and analytics;
- Internal research for technological improvement;
- Activities to maintain and improve our services; and
- Other one-time uses.
Recipients of California Personal Information. We disclose the categories of California Personal Information designated above for business purposes to the categories of third parties listed below:
- Service providers;
- Affiliates not under the Millicent brand; and
- Data analytics providers.
Your Rights Regarding California Personal Information. California residents have certain rights with respect to the personal information collected by businesses. If you are a California resident, you may exercise the following rights regarding your California Personal Information, subject to certain exceptions and limitations:
- The right to access the categories and specific pieces of personal information we have collected about you;
- The right to request the categories of sources from which we collected your personal information, our purposes for collecting your personal information, the categories of your personal information that we have disclosed for a business purpose, and the categories of third parties with which we have shared personal information; and
- The right to request that we delete the personal information we have collected from you.
To exercise any of the above rights, please contact us:
- By phone at 1-877-514-2221
- By email at privacy@millicentpharma.com
Note that we may need to request additional information from you to verify your identity or understand the scope of your request, although you will not be required to create an account with us to submit a request or have it fulfilled.
Nevada Privacy Rights
Under Nevada law, Nevada residents may submit a request directing us not to make certain disclosures of personal information we maintain about them.
To exercise this right, please contact us:
- By phone at 1-877-514-2221
- By email at privacy@millicentpharma.com
Changes to Our Privacy Policy
If our information practices change, we will post these changes on this page. We encourage you to visit this page periodically to learn of any updates.
Contact Us
If you have questions, comments, or concerns about this Privacy Policy, please contact us at: privacy@millicentpharma.com.
See More
Indication
INTRAROSA is a steroid indicated for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause.
Important Safety Information
INTRAROSA is contraindicated in women with undiagnosed abnormal genital bleeding.
Estrogen is a metabolite of prasterone. Use of exogenous estrogen is contraindicated in women with a known or suspected history of breast cancer. INTRAROSA has not been studied in women with a history of breast cancer.
In four 12-week randomized, placebo-controlled clinical trials, the most common adverse reaction with an incidence ≥2 percent was vaginal discharge. In one 52-week open-label clinical trial, the most common adverse reactions with an incidence ≥2 percent were vaginal discharge and abnormal Pap smear.
To report SUSPECTED ADVERSE REACTIONS, contact Millicent Pharma at 1-877-810-2101 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please see full Prescribing Information.
